Schroder Investment Management Group
INSY

Schroder Investment Management Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Schroder Investment Management Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-76,894
Closed -$845K – 1360
2017
Q1 		$845K Buy
76,894
+20,439
+36% +$218K ﹤0.01% 976
2016
Q4 		$519K Sell
56,455
-5,667
-9% -$64K ﹤0.01% 968
2016
Q3 		$732K Sell
62,122
-10,575
-15% -$161K ﹤0.01% 947
2016
Q2 		$941K Sell
72,697
-4,802
-6% -$70K ﹤0.01% 919
2016
Q1 		$1.23M Buy
+77,499
New +$1.47M ﹤0.01% 891

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schroder Investment Management Group's INSY Position: Q2 2017 in Review

Schroder Investment Management Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2017, closing a stake of 76,894 shares — an estimated $845K sold.

Schroder Investment Management Group first reported a position in INSY in Q1 2016 and held it in 5 quarters. The position peaked at $1.23M in Q1 2016. 118 funds tracked by Wall St. Rank hold INSY as of Q2 2017.

  • Schroder Investment Management Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Schroder Investment Management Group sold 76,894 Insys Therapeutics, Inc. shares in Q2 2017, an estimated $845K.
  • Schroder Investment Management Group first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 5 quarters.
  • Schroder Investment Management Group's Insys Therapeutics, Inc. position peaked at $1.23M in Q1 2016.
  • 118 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2017.

Based on Schroder Investment Management Group's 13F filing for Q2 2017, filed 10 Aug 2017.